Goldie RG et al. |
PAF receptors in guinea-pig and human lung. |
1990 |
Agents Actions Suppl. |
pmid:1964365
|
Alabaster VA et al. |
UK-74,505, a novel and selective PAF antagonist, exhibits potent and long lasting activity in vivo. |
1991 |
Agents Actions Suppl. |
pmid:1793066
|
Heuer HO |
The effects of hetrazepine PAF antagonists in preclinical models of asthma. |
1991 |
Agents Actions Suppl. |
pmid:1793067
|
Mazzoni L et al. |
Changes in airway sensitivity to histamine are not necessarily paralleled by changed sensitivity to acetylcholine. |
1991 |
Agents Actions Suppl. |
pmid:1793069
|
Billah MM et al. |
Sch 37370: a new drug combining antagonism of platelet-activating factor (PAF) with antagonism of histamine. |
1991 |
Agents Actions Suppl. |
pmid:1793070
|
Saeed SA et al. |
Inhibitory effect of oral ketotifen on ex vivo platelet activating factor-induced platelet aggregation. |
1991 |
Agents Actions Suppl. |
pmid:1793071
|
Hoshiko K et al. |
Histamine(H1) antagonists and airway hyperreactivity in the guinea-pig. |
1991 |
Agents Actions Suppl. |
pmid:1686527
|
Mest HJ et al. |
Effect of BN 52256 and other mediator antagonists on ouabain-induced ventricular fibrillation in sensitized guinea-pigs and on ischemia-induced fibrillation in rats. |
1992 |
Agents Actions Suppl. |
pmid:1632298
|
Koltai M and Braquet PG |
Involvement of PAF in atherogenesis. Brief review. |
1992 |
Agents Actions Suppl. |
pmid:1632308
|
McMillan RM and Carter GW |
Design and development of drugs. |
1991 |
Agents Actions Suppl. |
pmid:1664186
|
Rihoux JP |
The inhibiting effect of cetirizine 2 HC1 on eosinophil migration and its link to H1 blockade. |
1991 |
Agents Actions Suppl. |
pmid:1675836
|
Kurosawa M |
Effect of platelet activating factor on histamine release from rat mast cells. |
1987 |
Agents Actions Suppl. |
pmid:2445185
|
Page CP and Spina D |
The therapeutic relevance of PAF antagonists. |
1989 |
Agents Actions Suppl. |
pmid:2683635
|
Rink TJ |
Stimulus-response coupling mechanisms in human platelets. |
1986 |
Agents Actions Suppl. |
pmid:3028101
|
Baroggi N et al. |
Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds. |
1986 |
Agents Actions Suppl. |
pmid:3028108
|
Page CP et al. |
Drugs affecting pulmonary responses to platelet activating factor as novel anti-asthma drugs. |
1988 |
Agents Actions Suppl. |
pmid:3051932
|
Etienne A et al. |
Antithrombotic activity of BN 50341, a structurally new compound with anticalcic and PAF-antagonistic properties. |
1986 |
Agents Actions Suppl. |
pmid:3468781
|
|
PAF, platelets and asthma. Proceedings of a meeting. September 7-9, 1986. |
1987 |
Agents Actions Suppl. |
pmid:3478993
|
Farr RS et al. |
Platelet abnormalities in asthma--do they exist in humans? |
1987 |
Agents Actions Suppl. |
pmid:3478994
|
Menz G et al. |
Lack of PAF release in extrinsic asthma. |
1987 |
Agents Actions Suppl. |
pmid:3478995
|
Szczeklik A et al. |
Bleeding time and PAF-acether-induced platelet aggregation in atopy. |
1987 |
Agents Actions Suppl. |
pmid:3478996
|
Schmitz-Schumann M et al. |
Evidence of PAF release and platelet activation in analgesics-asthma-syndrome. |
1987 |
Agents Actions Suppl. |
pmid:3478999
|
Guinot P et al. |
Effects of BN 52063 on PAF-acether induced weal and flare in man. |
1987 |
Agents Actions Suppl. |
pmid:3479000
|
Lang M et al. |
Effects of the PAF-antagonist CV-3988 on PAF-induced changes in mucus secretion and in respiratory and circulatory variables in ferrets. |
1987 |
Agents Actions Suppl. |
pmid:3479001
|
Codde JP et al. |
Effects of altered prostanoid and lyso-PAF synthesis by marine oil diets on blood pressure of salt loaded spontaneously hypertensive rats. |
1987 |
Agents Actions Suppl. |
pmid:3481207
|
Barnes PJ |
New concepts in the pathogenesis of bronchial hyperresponsiveness. |
1987 |
Agents Actions Suppl. |
pmid:3314413
|
Mustard JF et al. |
Platelet activation--an overview. |
1987 |
Agents Actions Suppl. |
pmid:3314414
|
Page CP and Robertson DN |
Properties of PAF relevant to asthma. |
1987 |
Agents Actions Suppl. |
pmid:3314416
|
Morley J |
PAF and airway hyperreactivity; prospects for novel prophylactic anti-asthma drugs. |
1987 |
Agents Actions Suppl. |
pmid:3314417
|
Braquet P et al. |
The role of PAF-acether in anaphylaxis demonstrated with the use of the antagonist BN 52021. |
1987 |
Agents Actions Suppl. |
pmid:3314418
|
Morley J et al. |
Pharmacological evaluation of prophylactic anti-asthma drugs by reference to the pathological sequelae of exposure to allergen or platelet activating factor. |
1988 |
Agents Actions Suppl. |
pmid:3262989
|
Subissi A and Criscuoli M |
Effects of LG 30435 on different platelet activating factor-induced responses. |
1988 |
Agents Actions Suppl. |
pmid:3262990
|
Heuer H and Casals-Stenzel J |
Effect of the PAF-antagonist WEB 2086 on anaphylactic lung reaction: comparison of inhalative and intravenous challenge. |
1988 |
Agents Actions Suppl. |
pmid:3262991
|
Anderson GP and Fennessy MR |
Lipoxygenase metabolites as mediators of platelet activating factor-induced increased airways responsiveness to histamine in the guinea-pig. |
1988 |
Agents Actions Suppl. |
pmid:3140616
|
Schrör K and Felsch A |
Ramiprilat prevents PAF-induced myocellular and endothelial injury in a neutrophil-perfused heart preparation. |
1992 |
Agents Actions Suppl. |
pmid:1334351
|
Stenzel H et al. |
Effect of the PAF-antagonist SRI 63-441 on the allergic reaction in awake dogs with natural asthma. |
1987 |
Agents Actions Suppl. |
pmid:2823582
|
O'Flaherty JT and Wykle RL |
Metabolic origin and fate of platelet-activating factor. |
1987 |
Agents Actions Suppl. |
pmid:2823583
|
Bertrand C et al. |
Selective implication of thromboxane A2 and PAF-acether in two guinea pig anaphylactic models. |
1990 |
Agents Actions Suppl. |
pmid:2080755
|
Tsunoda H et al. |
Effects of a novel PAF antagonist, E6123, on PAF-induced biological responses. |
1990 |
Agents Actions Suppl. |
pmid:2080757
|
Sakuma Y et al. |
Effects of a novel PAF antagonist, E6123, on passive anaphylaxis. |
1990 |
Agents Actions Suppl. |
pmid:2080758
|
Soloviev A and Braquet P |
The similarity in action of hypoxia and platelet-activating factor on smooth muscle cells of coronary arteries: possible explanation for hypoxic coronary spasm development. |
1995 |
Agents Actions Suppl. |
pmid:7717190
|
Bult H et al. |
Complement derived factors and prostacyclin formation by rabbit isolated peritoneum and cultured mesothelial cells. |
1984 |
Agents Actions Suppl. |
pmid:6382974
|
König W et al. |
On the biological role of lipid chemotactic factors. |
1983 |
Agents Actions Suppl. |
pmid:6404145
|
Parnham MJ et al. |
Regulation of the oxidative burst of macrophages by lipid mediators. |
1984 |
Agents Actions Suppl. |
pmid:6433680
|
Hartung HP et al. |
Stimulation of the oxidative burst in macrophages with platelet activating factor (PAF-acether). |
1982 |
Agents Actions Suppl. |
pmid:6960648
|
Chini M et al. |
Effects of HAART on platelet-activating factor metabolism in naive HIV-infected patients I: study of the tenofovir-DF/emtricitabine/efavirenz HAART regimen. |
2012 |
AIDS Res. Hum. Retroviruses |
pmid:22050695
|
Lima RG et al. |
Interaction of macrophages with apoptotic cells enhances HIV Type 1 replication through PGE2, PAF, and vitronectin receptor. |
2006 |
AIDS Res. Hum. Retroviruses |
pmid:16910832
|
Tsoupras AB et al. |
Anti-platelet-activating factor effects of highly active antiretroviral therapy (HAART): a new insight in the drug therapy of HIV infection? |
2008 |
AIDS Res. Hum. Retroviruses |
pmid:18620493
|
Kelesidis T et al. |
The Role of Platelet-Activating Factor in Chronic Inflammation, Immune Activation, and Comorbidities Associated with HIV Infection. |
|
AIDS Rev |
pmid:26616844
|
Saleh AA et al. |
Effect of alcohol on platelet-activating factor acetylhydrolase activity in pregnant and nonpregnant mice. |
1994 |
Alcohol. Clin. Exp. Res. |
pmid:7978079
|